spacer gif spacer gif spacer gif spacer gif spacer gif
 QUICK SEARCH:   [advanced]


spacer gif
     Home     Help     Feedback     Subscriptions     Archive     Search     Table of Contents    


This Article
Right arrow Summary Freely available
Right arrow Full Text
Right arrow Full Text (PDF)
Right arrow Alert me when this article is cited
Right arrow Alert me if a correction is posted
Services
Right arrow Email this article to a friend
Right arrow Related articles in JCS
Right arrow Similar articles in this journal
Right arrow Similar articles in PubMed
Right arrow Alert me to new issues of the journal
Right arrow Download to citation manager
Right arrow reprints & permissions
Citing Articles
Right arrow Citing Articles via HighWire
Right arrow Citing Articles via Google Scholar
Google Scholar
Right arrow Articles by Koticha, D. K.
Right arrow Articles by Baldini, G.
Right arrow Search for Related Content
PubMed
Right arrow PubMed Citation
Right arrow Articles by Koticha, D. K.
Right arrow Articles by Baldini, G.

Plasma membrane targeting of SNAP-25 increases its local concentration and is necessary for SNARE complex formation and regulated exocytosis

Darshan K. Koticha, Ellen E. McCarthy and Giulia Baldini*

Department of Anatomy and Cell Biology, Columbia University, College of Physicians and Surgeons, New York, NY 10032, USA



View larger version (37K):

[in a new window]
 
Fig. 1. POMC-ß-Gal is processed and secreted in a Ca2+-dependent manner. (A) Neuro2A cells expressing either POMC-ß-Gal or ß-Gal were homogenized (H) in homogenization buffer with protease inhibitors and centrifuged at 95,000 rpm for 30 minutes in a Beckman TLA 100.1 to obtain a membrane-containing pellet (P) or cytosol containing supernatant (S) as described previously (Koticha et al., 1999Go). Equal volumes (40 µl) of the samples were electrophoresed on 9% SDS-PAGE gels, transferred to nitrocellulose membranes and probed with anti-ß-Gal antibodies. The arrowheads indicate bands that are detected with both the antibody against ß-Gal and the antibody against ACTH. The upper arrow indicates the 124 kDa product of POMC-ß-Gal cleavage. The lower arrow indicates ß-Gal. (B) Post-nuclear supernatants (PNS) derived from N2A cells (0.4 ml) were centrifuged at 7,200 g for 10 minutes to obtain a pellet P1 and a supernatant S1. The pellet P1 was re-suspended in 0.4 ml of homogenization buffer. Equal volumes (40 µl) of the fractions were loaded onto an SDS-PAGE gels, transferred to nitrocellulose membranes and probed with anti-Na+/K+ ATPase, anti-ß-Gal antibodies, anti-Mannose-6-Phophate receptor (M6PR) and anti Rab3 (monoclonal 42.1) antibodies. (C) Confocal immunofluorescence of cells stained with anti-Rab3 antibody 42.1. The arrows indicate Rab3 immunoreactivity at the tips. Bar, 10 µm. (D) The supernatant S1 was derived as in B was centrifuged at 70,000 g for 30 minutes, and the pellet was loaded onto a 20-60% (w/v) sucrose density gradient. The gradient was centrifuged at 50,000 rpm in the Beckman TLS-55 swinging bucket rotor. Fractions were collected from the top and analyzed by western blot with anti-mannose-6-phophate receptor antibodies (open triangles), anti-Rab3 antibodies (closed squares) and anti-ß-Gal antibodies (closed circles, the 124/120 kDa band). (E) Neuro2A cells grown in 65 mm wells expressing POMC-ß-Gal were pre-incubated at 37°C for 30 minutes in 1.0 ml M2 buffer with 0.7 mM CaCl2. Cells were then incubated with 1 ml of M2 with or without 1 µM Ionomycin at 37°C for 1 hour. SDS-PAGE gel lanes were loaded with 50 µl of the cell medium. Western blot analysis of the secreted POMC-ß-Gal products was performed using antibodies against ß-Gal. Densitometry of the bands was done using the NIH Image 1.61 software. This experiment was done three times. (F) Release of ß-Gal activity (% age of total activity in cells) was measured from cells either incubated with Ca2+ alone (-) or treated with Ionomycin for 60 minutes (+) or depolarized by KCl for 120 minutes (+), as described in the Materials and Methods. The ß-Gal activity release is an average of data from triplicate samples of a single experiment. This experiment was done four times with similar results. (G) The cells were incubated with Ca2+ alone (basal conditions) or with Ca2+ and Ionomycin (stimulated conditions) for 0-30, 0-60 and 0-90 minutes. Ca2+-dependent ß-Gal release (percentage of total activity in cells)=Rst-Rbt, where Rst is the percentage of the total cell ß-Gal activity that is released by samples stimulated with Ca2+ and Ionomycin, and Rbt is the percentage of the total cell ß-Gal activity that is released by samples kept in basal conditions. The average is calculated from the data of three independent experiments done with triplicate samples.

 


View larger version (35K):

[in a new window]
 
Fig. 2. SNAP-25 is required for Ca2+-dependent secretion in Neuro2A cells. (A) Homogenates of Neuro2A cells were analyzed by western blot with antibodies against Syntaxin-1, SNAP-25, VAMP-2 and Syndet. (B) Confocal immunofluorescence image of wild-type Neuro2A cells stained with antibodies against SNAP-25. (C) Confocal immunofluorescence image of Neuro2A cells expressing myc-tagged SNAP-25A stained with antibodies against myc. Bar, 15 µm. (D) Neuro2A cells were transiently transfected with POMC-ß-Gal and pcDNA3.1 or with POMC-ß-Gal and BoNT/E-pcDNA3.1. Ca2+-dependent ß-Gal release is measured as described in Fig. 1G. The average is calculated from the data of four independent experiments done with triplicate samples. (E) Neuro2A cells were transiently transfected with pcDNA3.1 (-) or BoNT/E-pcDNA3.1 (+) alone (lanes 1-4) or in combination with Syndet-pcB7 (lane 5 and 6) and Syndet-Delta-BoNT/E-pcB7 (Koticha et al., 1999Go) (lane 7). Syndet-Delta-BoNT/E protein expressed in Neuro2A cells is a truncated protein that is identical to the expected product of Syndet digested by BoNT/E (arrowhead) (Washbourne et al., 2001Go). The western blot was probed with anti-SNAP-25 and anti-Syndet antibodies, as indicated.

 


View larger version (18K):

[in a new window]
 
Fig. 3. The cysteine-rich domain of SNAP-25 is necessary for membrane binding. (A) The SNAP-25A mutants used in this study. BonT/E-resistant SNAP-25 SNAP-25A/ER (S25A/ER) has amino acids 179Asp and 182Met changed to 179Lys and 182Thr. BonT/E-resistant Delta-SNAP-25A/ER (Delta-S25A/ER) lacks 11 amino acids corresponding to the cysteine-rich domain of SNAP-25A and has the corresponding Asp and Met residues changed to Lys and Thr. BonT/E-resistant CA-SNAP-25A/ER (CA-S25A/ER) has all cysteines substituted with alanines and has amino acids 179Asp and 182Met changed to 179Lys and 182Thr. (B) Fractionation of cells transiently expressing wild-type SNAP-25A or Delta-SNAP-25A. Post-nuclear supernatants from these cells were centrifuged as described in Fig. 1 and separated into membrane pellet (P) or cytosol (S). Equal volumes of the fractions were then loaded onto a 13% SDS-PAGE gel, transferred and probed with anti-Myc antibody. (C) Fractionation of cells transiently expressing either wild-type SNAP-25A or CA-SNAP-25A. This experiment was done as described in panel B.

 


View larger version (16K):

[in a new window]
 
Fig. 4. Expression of BoNT/E-resistant SNAP-25A mutants does not inhibit the cleavage of endogenous SNAP-25 by the toxin. (A) Homogenates of wild-type Neuro2A cells (lane 1) and of cells stably expressing BoNT/E, the G14 cells (lane 2-4). G14 cells were transiently transfected with POMC-ß-Gal together with either pcB7 (lane 2) or SNAP-25A/ER-pcB7 (lane 3) or Delta-SNAP-25A/ER-pcB7 (lane 4). Homogenates of cells expressing the indicated constructs were electrophoresed on 13% SDS-PAGE gels, and western blots were probed with anti-SNAP-25 antibody. The arrowhead indicates the endogenous SNAP-25. (B) Release of ß-Gal activity under basal conditions from G14 cells and wild-type Neuro2A cells transfected with POMC-ß-Gal construct. The release is calculated as a percentage of the total ß-Gal activity in the cells.

 


View larger version (33K):

[in a new window]
 
Fig. 5. The cysteine-rich domain of SNAP-25 is necessary to support regulated exocytosis in intact cells. (A) Ca2+-dependent secretion of ß-Gal activity in G14 cells stably expressing BoNT/E and transiently transfected with POMC-ß-Gal and pcB7 or SNAP-25A/ER-pcB7 or Delta-SNAP-25A/ER-pcB7. (B) Ca2+-dependent secretion of ß-Gal activity in G14 cells stably expressing BoNT/E and transiently transfected with POMC-ß-Gal and pcB7 or SNAP-25A/ER-pcB7 or CA-SNAP-25A/ER-pcB7. Ca2+-dependent ß-Gal release (as in Fig. 1G) is calculated from the data of four independent experiments done with triplicate samples.

 


View larger version (22K):

[in a new window]
 
Fig. 6. The cysteine-rich domain of SNAP-25 is important for SNARE complex formation in intact cells. (A) Post-nuclear supernatants in sample buffer were prepared as described in the Materials and Methods. The samples were either not boiled (-) or boiled (+) and loaded on a 9% SDS-PAGE gel. SNAP-25 complexes from G14 cells transiently transfected with 5 µg of POMC-ß-Gal together with 5 µg of pcB7 or SNAP-25A/ER-pcB7 (S25A) or CA-SNAP-25A/ER-pcB7 (CA S25A) were detected by western blot analysis with anti-SNAP-25 antibody. The arrowhead indicates SNARE complexes formed by exogenous SNAP-25 and the double arrow indicated SNAP-25 complexes formed by endogenous SNAP-25. (B) The western blot of a similar experiment was probed with anti-Myc antibody. (C) The total amount of SNAP-25 protein expressed in the transfected cells shown in A is detected with the anti-SNAP25 antibody. (D) SNAP-25 complexes from G14 cells transiently transfected with POMC-ß-Gal together with either SNAP-25A/ER-pcB7 or Delta-SNAP-25A/ER-pcB7 were detected as described in A. (E) The total amount of SNAP-25 monomer expressed in these cells was detected as in C. These experiments were repeated three times with triplicate samples per experiment. (F) SNAP-25 complexes from G14 cells transiently transfected with the indicated amounts (µg) of POMC-ß-Gal and CA-SNAP-25A/ER-pcB7 or CA-SNAP-25A/ER-pcB7 alone. The arrowhead indicates SNARE complexes formed by exogenous SNAP-25 and the double arrow indicates complexes formed by endogenous SNAP-25. The total amount of CA-SNAP-25A/ER expressed in the cells is shown in the lower panel. The western blot was probed with the anti-SNAP-25 antibody.

 


View larger version (28K):

[in a new window]
 
Fig. 7. The two helices of SNAP-25 can function independently of each other in regulated exocytosis. (A) A SNAP-25 construct called S25A/ER-82-206-pcB7, lacking the N-terminal helical region and containing amino acids 82-206 was generated. (B) Confocal immunofluorescence image of Neuro2A cells expressing myc-tagged S25A/ER-82-206 stained with antibodies against myc. Bar, 15 µm. (C) Ca2+-dependent secretion of ß-Gal activity (percentage of total activity in cells) was derived as in Fig. 5 A. ß-Gal secretion is measured in G14 cells stably expressing BoNT/E and transiently transfected with POMC-ß-Gal and pcB7 or S25A/ER-82-20-pcB7. Ca2+-dependent release of ß-Gal (as in Fig. 1G) is calculated from the data of four independent experiments done with triplicate samples as in Fig. 1. (D) SNARE complexes derived from G14 cells transiently transfected with POMC-ß-Gal together with either pcB7 or S25A/ER-82-206-pcB7 were detected as described in Fig. 6. The total amount of S25A/ER-82-206 expressed is shown in the lower panel probed with anti-myc antibodies.

 





© The Company of Biologists Ltd 2002